The SAPIT trial provides essential evidence on risks and benefits of integrated and sequential treatment of HIV and tuberculosis

S Afr Med J. 2010 Dec 1;100(12):808-9. doi: 10.7196/samj.4621.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • Antitubercular Agents / therapeutic use*
  • Clinical Trials as Topic / methods*
  • Drug Therapy, Combination
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV*
  • Humans
  • South Africa
  • Tuberculosis / complications
  • Tuberculosis / drug therapy*

Substances

  • Anti-Retroviral Agents
  • Antitubercular Agents